Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
EP 2624836
BEPOTASTIN-ZUSAMMENSETZUNG
granted -
US 8507687
Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
granted -
US 8507672
Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitors
granted -
US 8507551
Antimicrobial therapy for bacterial infections
granted -
US 8507447
Treatments for gastrointestinal disorders
granted -
US 8506944
Replenishment and enrichment of ocular surface lubrication
granted -
US 8507663
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
granted -
US 8507012
Formulations comprising extracts from primitive plant species (mosses, ferns and lichens) to treat and prevent cancers
granted -
US 8507522
Hepatitis C virus inhibitors
granted -
US 8507455
Folate conjugates
granted -
US 8507524
Modulators of ATP-binding cassette-transporters
granted -
US 8507463
Nucleotide analogue prodrug and the preparation thereof
granted -
US 8507534
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
granted -
US 8507445
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
granted -
US 8507437
Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same
granted -
US 8507206
Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)
granted -
US 8507435
Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof
granted -
US 8507433
Cardioprotective effects of GHRH agonists
granted -
US 8507195
MiRNAs dysregulated in triple-negative breast cancer
granted -
US 8506961
Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their use
granted -
US 8506947
Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell
granted -
US 8506959
Prevention and treatment of synucleinopathic and amyloidogenic disease
granted -
US 8506928
Methods and compounds for targeting tissues
granted -
US 8507675
Compositions and methods for inhibition of the JAK pathway
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.